Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Cardiology ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Obesity and the risk of heart failure.N Engl J Med. 2002; 347: 305-313
- Increased heart failure risk in normal-weight people with metabolic syndrome compared with metabolically healthy obese individuals.J Am Coll Cardiol. 2011; 58: 1343-1350
- The relationship between obesity and mortality in patients with heart failure.J Am Coll Cardiol. 2001; 38: 789-795
- Pre-morbid body mass index and mortality after incident heart failure: the ARIC Study.J Am Coll Cardiol. 2014; 64: 2743-2749
- Body mass index and mortality in heart failure: a meta-analysis.Am Heart J. 2008; 156: 13-22
- Body mass index and all-cause mortality in heart failure patients with normal and reduced ventricular ejection fraction: a dose–response meta-analysis.Clin Res Cardiol. 2019; 108: 119-132
- Protective overweight in cardiovascular disease: moving from “paradox” to “paradigm.Eur Heart J. 2015; 36: 2729-2732
- Wasting as independent risk factor for mortality in chronic heart failure.Lancet. 1997; 349: 1050-1053
- Guidelines for the diagnosis and treatment of chronic heart failure.Eur Heart J. 2001; 22: 1527-1560
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012.Eur Heart J. 2012; 33: 1787-1847
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.Eur J Heart Fail. 2016; 18: 891-975
- Identifying pathophysiological mechanisms in heart failure with reduced versus preserved ejection fraction.J Am Coll Cardiol. 2018; 72: 1081-1090
- Pitfalls in the measurement of muscle mass: a need for a reference standard.J Cachexia Sarcopenia Muscle. 2018; 9: 269-278
- Impact of incident heart failure on body composition over time in the health ABC study population.Circ Heart Fail. 2017; 10 ([pii:e003915])
- The wasting continuum in heart failure: from sarcopenia to cachexia.Proc Nutr Soc. 2015; 74: 367-377
- Intestinal congestion and right ventricular dysfunction: a link with appetite loss, inflammation, and cachexia in chronic heart failure.Eur Heart J. 2016; 37: 1684-1691
- Relationships between right ventricular function, body composition, and prognosis in advanced heart failure.J Am Coll Cardiol. 2013; 62: 1660-1670
- Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure.Eur Heart J. 1999; 20: 683-693
- Comparison of sarcopenia and cachexia in men with chronic heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF).Eur J Heart Fail. 2018; 20: 1580-1587
- Wasting of the left ventricle in patients with cardiac cachexia: a cardiovascular magnetic resonance study.Int J Cardiol. 2004; 97: 15-20
- Loss of bone mineral in patients with cachexia due to chronic heart failure.Am J Cardiol. 1999; 83: 612-615
- Prevalence and clinical impact of cachexia in chronic illness in Europe, USA, and Japan: facts and numbers update 2016.J Cachexia Sarcopenia Muscle. 2016; 7: 507-509
- Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study.Lancet. 2003; 361: 1077-1083
- Cachexia: a new definition.Clin Nutr. 2008; 27: 793-799
- Prognostic significance of monthly weight fluctuations among older nursing home residents.J Gerontol A Biol Sci Med Sci. 2004; 59: M633-M639
- Cachexia: a nutritional syndrome?.J Cachexia Sarcopenia Muscle. 2015; 6: 269-271
- Muscle wasting and sarcopenia in heart failure: a brief overview of the current literature.ESC Heart Fail. 2018; 5: 1074-1082
- Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF).Eur Heart J. 2013; 34: 512-519
- Sarcopenia in patients with heart failure with preserved ejection fraction: impact on muscle strength, exercise capacity and quality of life.Int J Cardiol. 2016; 222: 41-46
- Muscle wasting in young patients with dilated cardiomyopathy.J Cachexia Sarcopenia Muscle. 2017; 8: 542-548
- The cardiac component of cardiac cachexia.Am Heart J. 2002; 144: 45-50
- Symptom improvement and cachexia reversal in an 84-year-old woman after percutaneous closure of atrial septal defect.J Am Geriatr Soc. 2015; 63: 416-418
- The putative satiety hormone PYY is raised in cardiac cachexia associated with primary pulmonary hypertension.Heart. 2005; 91: 241-242
- Prevalence of cachexia in chronic heart failure and characteristics of body composition and metabolic status.Endocrine. 2013; 43: 626-634
- Serial echocardiographic characteristics, novel biomarkers and cachexia development in patients with stable chronic heart failure.J Cardiovasc Transl Res. 2016; 9: 429-431
- Animal models of cachexia and sarcopenia in chronic illness: cardiac function, body composition changes and therapeutic results.Int J Cardiol. 2017; 238: 12-18
- Cancer cachexia: understanding the molecular basis.Nat Rev Cancer. 2014; 14: 754-762
- MicroRNAs in muscle wasting and cachexia induced by heart failure.Nat Rev Cardiol. 2017; 14: 566
- Increased expression of the mRNA for hormone-sensitive lipase in adipose tissue of cancer patients.Biochim Biophys Acta. 1993; 1180: 236-242
- Functional and pharmacological characterization of the natriuretic peptide-dependent lipolytic pathway in human fat cells.J Pharmacol Exp Ther. 2004; 308: 984-992
- The syndrome of cardiac cachexia.Int J Cardiol. 2002; 85: 51-66
- Neurohormonal modulation in chronic heart failure.Eur Heart J Suppl. 2002; 4: D3-D11
- Mechanisms of cachexia in chronic disease states.Am J Med Sci. 2015; 350: 250-256
- The molecular basis of skeletal muscle atrophy.Am J Physiol Cell Physiol. 2004; 287: C834-C843
- Pathophysiology and treatment of inflammatory anorexia in chronic disease.J Cachexia Sarcopenia Muscle. 2010; 1: 135-145
- Anthropometric variables and physical activity as predictors of cardiac cachexia.Int J Cardiol. 2005; 99: 239-245
- Cancer cachexia—pathophysiology and management.J Gastroenterol. 2013; 48: 574-594
- Acylated ghrelin treatment normalizes skeletal muscle mitochondrial oxidative capacity and AKT phosphorylation in rat chronic heart failure.J Cachexia Sarcopenia Muscle. 2017; 8: 991-998
- Fat malabsorption in elderly patients with cardiac cachexia.Age Ageing. 1996; 25: 144-149
- Collagen accumulation and dysfunctional mucosal barrier of the small intestine in patients with chronic heart failure.Int J Cardiol. 2008; 125: 240-245
- Studies on bacterial endotoxin and intestinal absorption function in patients with chronic heart failure.Int J Cardiol. 2012; 157: 80-85
- Gastro-intestinal protein loss in elderly patients with cardiac cachexia.Age Ageing. 1996; 25: 221-223
- Intestinal blood flow in patients with chronic heart failure: a link with bacterial growth, gastrointestinal symptoms, and cachexia.J Am Coll Cardiol. 2014; 64: 1092-1102
- An obesity-associated gut microbiome with increased capacity for energy harvest.Nature. 2006; 444: 1027-1031
- Heart failure is associated with depletion of core intestinal microbiota.ESC Heart Fail. 2017; 4: 282-290
- Effect of beta-adrenergic blockade with carvedilol on cachexia in severe chronic heart failure: results from the COPERNICUS trial.J Cachexia Sarcopenia Muscle. 2017; 8: 549-556
- Beta blocker dose and markers of sympathetic activation in heart failure patients: interrelationships and prognostic significance.ESC Heart Fail. 2017; 4: 499-506
- Exercise training attenuates MuRF-1 expression in the skeletal muscle of patients with chronic heart failure independent of age.Circulation. 2012; 125: 2716-2727
- The effects of a high-caloric protein-rich oral nutritional supplement in patients with chronic heart failure and cachexia on quality of life, body composition, and inflammation markers: a randomized, double-blind pilot study.J Cachexia Sarcopenia Muscle. 2010; 1: 35-42
- Ferric carboxymaltose in patients with heart failure and iron deficiency.N Engl J Med. 2009; 361: 2436-2448
- Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency†.Eur Heart J. 2015; 36: 657-668
- Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study.J Am Coll Cardiol. 2009; 54: 919-927
- Testosterone therapy in women with chronic heart failure: a pilot double-blind, randomized, placebo-controlled study.J Am Coll Cardiol. 2010; 56: 1310-1316
- Testosterone therapy during exercise rehabilitation in male patients with chronic heart failure who have low testosterone status: a double-blind randomized controlled feasibility study.Am Heart J. 2012; 164: 893-901
- Iron deficiency as energetic insult to skeletal muscle in chronic diseases.J Cachexia Sarcopenia Muscle. 2018; 9: 802-815
- Depleted iron stores are associated with inspiratory muscle weakness independently of skeletal muscle mass in men with systolic chronic heart failure.J Cachexia Sarcopenia Muscle. 2018; 9: 547-556
- Elevated circulating level of ghrelin in cachexia associated with chronic heart failure.Circulation. 2001; 104: 2034-2038
- Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity.J Card Fail. 2003; 9: 29-35
- Relation of respiratory muscle strength, cachexia and survival in severe chronic heart failure.J Cachexia Sarcopenia Muscle. 2013; 4: 277-285
- Plasma adiponectin in heart failure with and without cachexia: catabolic signal linking catabolism, symptomatic status, and prognosis.Nutr Metab Cardiovasc Dis. 2014; 24: 50-56
- Cachexia in hospitalized patients with heart failure.Nutr Hosp. 2018; 35: 669-676
- Sarcopenia in daily practice: assessment and management.BMC Geriatr. 2016; 16: 170
Article Info
Footnotes
This article originally appeared in Heart Failure Clinics, Volume 16, Issue 1, January 2020.
Disclosure Statement: The authors have nothing to disclose.
Identification
Copyright
© 2021 Elsevier Inc. All rights reserved.
